Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol

NCT02533427 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

HCV Infection

Interventions

DRUG: SOF/VEL/VOX
DRUG: VOX
DRUG: Norgestimate/ethinyl estradiol

Sponsor

Gilead Sciences